206 related articles for article (PubMed ID: 15247468)
1. Immunotherapy: bewitched, bothered, and bewildered no more.
Steinman RM; Mellman I
Science; 2004 Jul; 305(5681):197-200. PubMed ID: 15247468
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell immunotherapy: mapping the way.
Figdor CG; de Vries IJ; Lesterhuis WJ; Melief CJ
Nat Med; 2004 May; 10(5):475-80. PubMed ID: 15122249
[TBL] [Abstract][Full Text] [Related]
3. DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy.
Schultze JL; Grabbe S; von Bergwelt-Baildon MS
Trends Immunol; 2004 Dec; 25(12):659-64. PubMed ID: 15530836
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy with dendritic cells for cancer.
Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A
Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells in cancer immunotherapy.
Vulink A; Radford KJ; Melief C; Hart DN
Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
[TBL] [Abstract][Full Text] [Related]
6. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
[TBL] [Abstract][Full Text] [Related]
7. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
Lynch DH
Immunol Rev; 2008 Apr; 222():277-86. PubMed ID: 18364008
[TBL] [Abstract][Full Text] [Related]
8. Priming anticancer active specific immunotherapy with dendritic cells.
Mocellin S
Curr Opin Investig Drugs; 2005 Jun; 6(6):576-81. PubMed ID: 15988908
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell vaccines in melanoma: from promise to proof?
Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ
Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431
[TBL] [Abstract][Full Text] [Related]
10. Optimizing dendritic cell-based immunotherapy for cancer.
Zhong H; Shurin MR; Han B
Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells as therapeutic vaccines against cancer.
Banchereau J; Palucka AK
Nat Rev Immunol; 2005 Apr; 5(4):296-306. PubMed ID: 15803149
[TBL] [Abstract][Full Text] [Related]
12. Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells.
Breckpot K; Heirman C; Neyns B; Thielemans K
J Gene Med; 2004 Nov; 6(11):1175-88. PubMed ID: 15468193
[TBL] [Abstract][Full Text] [Related]
13. Cancer vaccines.
Chekhun VF
Exp Oncol; 2008 Jun; 30(2):90. PubMed ID: 18680872
[No Abstract] [Full Text] [Related]
14. Dendritic cell immunotherapy for the treatment of neoplastic disease.
Decker WK; Xing D; Shpall EJ
Biol Blood Marrow Transplant; 2006 Feb; 12(2):113-25. PubMed ID: 16443510
[TBL] [Abstract][Full Text] [Related]
15. Cell based cancer vaccines: regulatory and commercial development.
Copier J; Ward S; Dalgleish A
Vaccine; 2007 Sep; 25 Suppl 2():B35-46. PubMed ID: 17916462
[TBL] [Abstract][Full Text] [Related]
16. Cellular immunotherapy with dendritic cells in cancer: current status.
Nencioni A; Brossart P
Stem Cells; 2004; 22(4):501-13. PubMed ID: 15277696
[TBL] [Abstract][Full Text] [Related]
17. Cell fusion: from hybridoma to dendritic cell-based vaccine.
Gong J; Koido S; Calderwood SK
Expert Rev Vaccines; 2008 Sep; 7(7):1055-68. PubMed ID: 18767954
[TBL] [Abstract][Full Text] [Related]
18. [Dendrite cell-based cancer vaccines--clinical application].
Svane IM; Berntsen A; Trepiakas R; Pedersen AE
Ugeskr Laeger; 2006 Apr; 168(14):1415-20. PubMed ID: 16584668
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in therapeutic cancer vaccines.
Morse MA; Chui S; Hobeika A; Lyerly HK; Clay T
Nat Clin Pract Oncol; 2005 Feb; 2(2):108-13. PubMed ID: 16264883
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells for active immunotherapy: optimizing design and manufacture in order to develop commercially and clinically viable products.
Nicolette CA; Healey D; Tcherepanova I; Whelton P; Monesmith T; Coombs L; Finke LH; Whiteside T; Miesowicz F
Vaccine; 2007 Sep; 25 Suppl 2():B47-60. PubMed ID: 17669561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
